Clinical trial
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus…
NCT00326183 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00326183 |
|---|---|
| Title | Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) |
| Official title | An Open, Multicenter Study of the Safety and Tolerability of VAQTA(TM) and ProQuad(TM) in Healthy Children 12 to 23 Months of Age |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis A, Measles, Mumps, Rubella, Chickenpox |
| Intervention type | Biological |
| Interventions | VAQTA®, ProQuad |
| Enrollment | 1,800 |
| Start date | Mar 26, 2007 |
| Primary completion | Jan 15, 2008 |
| Completion | Jan 15, 2008 |
| First posted | May 16, 2006 |
| Last update posted | Feb 4, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: